Deepinder Goyal, one of India’s most respected self-made entrepreneurs and the visionary behind Zomato, has announced the launch of Continue Research, an ambitious scientific initiative backed by his $25 million personal fund dedicated to advancing global longevity science. Known for his commitment to entrepreneurship, innovation, and mentorship, Goyal’s latest venture steps beyond business to explore one of humanity’s most profound frontiers extending and improving the quality of human life.
Financial Technology Insights: Begini, BOP Partner to Advance AI Financial Inclusion
Founded two years ago, Continue Research operates as an independent scientific collective focused on understanding the upstream biological mechanisms that influence how humans age and live. The initiative explores core hypotheses around human aging, targeting the fundamental leverage points in biology where small interventions could dramatically impact longevity and overall well-being. If validated, these findings could reshape current scientific understanding of human biology.
Financial Technology Insights: Western Alliance Funds 200 Affordable Homes in N. Vegas
Unlike traditional ventures, Continue Research is entirely self-funded by Goyal. Through the $25 million Continue Fund, the initiative will support scientists across the world who take a systems-level approach to biology, challenging conventional frameworks in life sciences. Importantly, all research outcomes from Continue and its global collaborators will be made open-source, reinforcing Goyal’s belief in the democratization of science and accessibility of knowledge.
Financial Technology Insights: Cybrid Raises $10 Million to Boost Stablecoin Infrastructure
Reflecting Goyal’s philosophy of science for all, Continue Research focuses on discoveries that can benefit entire populations — not just the privileged few. It is structured not as a company or a startup, but as a research collective and seed fund aimed at catalyzing the next phase of human existence.
With Continue Research, Deepinder Goyal is bridging the worlds of technology, innovation, and biology advancing a vision where human longevity is not just extended, but meaningfully enhanced for generations to come.
To share your insights with the FinTech Newsroom, please write to us at sudipto@intentamplify.com